famotidine has been researched along with cisapride in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (33.33) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Horikoshi, T; Kobayashi, S; Kusano, M; Matsuzaki, T; Nishioka, T; Ohwada, T; Sekiguchi, T; Sugiyama, M; Toki, M | 1 |
Dallera, F; Gendarini, A; Scanzi, G | 1 |
Berstad, A; Hatlebakk, JG | 1 |
Itoh, Z; Matsunaga, Y; Tamaki, H; Ueki, S; Yoneta, T | 1 |
Grodzieński, R; Radwan, P; Skrzydło-Radomańska, B; Słomka, M; Wysokiński, A; Zaorska-Rajca, J | 1 |
Adachi, K; Fujishiro, H; Kawamura, A; Kinoshita, Y; Ono, M; Yuki, M | 1 |
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
1 review(s) available for famotidine and cisapride
Article | Year |
---|---|
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Benzimidazoles; Cimetidine; Cisapride; Domperidone; Famotidine; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Metoclopramide; Nizatidine; Omeprazole; Pantoprazole; Piperidines; Proton Pump Inhibitors; Ranitidine; Sucralfate; Sulfoxides | 1996 |
1 trial(s) available for famotidine and cisapride
Article | Year |
---|---|
[The effect of prokinetic treatment and eradication of Helicobacter pylori on gastric emptying and symptoms of functional dyspepsia].
Topics: Adolescent; Adult; Cisapride; Drug Therapy, Combination; Dyspepsia; Famotidine; Female; Gastric Emptying; Helicobacter Infections; Helicobacter pylori; Humans; Male | 2001 |
10 other study(ies) available for famotidine and cisapride
Article | Year |
---|---|
Comparative efficacy of acid reflux inhibition by drug therapy in reflux esophagitis.
Topics: Adult; Aged; Chronic Disease; Cisapride; Esophagitis, Peptic; Esophagus; Famotidine; Female; Humans; Hydrogen-Ion Concentration; Male; Monitoring, Physiologic; Omeprazole; Piperidines; Serotonin Antagonists; Stomach | 1991 |
[Prokinetic activity and antral inflammation. Usefulness of cisapride combined with H2 antagonists in gastritis].
Topics: Anti-Ulcer Agents; Cisapride; Drug Therapy, Combination; Famotidine; Female; Gastritis; Gastrointestinal Motility; Humans; Male; Piperidines; Pyloric Antrum | 1994 |
Gastroprokinetic activity of nizatidine during the digestive state in the dog and rat.
Topics: Animals; Anti-Ulcer Agents; Cimetidine; Cisapride; Digestion; Dogs; Duodenum; Famotidine; Gastric Emptying; Gastrointestinal Motility; Injections, Intravenous; Intubation, Gastrointestinal; Male; Nizatidine; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Stomach | 1999 |
Nizatidine and cisapride enhance salivary secretion in humans.
Topics: Adult; Anti-Ulcer Agents; Bicarbonates; Case-Control Studies; Cisapride; Epidermal Growth Factor; Famotidine; Humans; Male; Nizatidine; Saliva; Salivation | 2002 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |